These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Vulvar involvement in autoimmune bullous diseases. Marren P; Wojnarowska F; Venning V; Wilson C; Nayar M J Reprod Med; 1993 Feb; 38(2):101-7. PubMed ID: 8445600 [TBL] [Abstract][Full Text] [Related]
27. Autoimmune bullous dermatoses: a review. Bickle K; Roark TR; Hsu S Am Fam Physician; 2002 May; 65(9):1861-70. PubMed ID: 12018809 [TBL] [Abstract][Full Text] [Related]
28. Beyond the skin: disease parameters in pemphigus. Viti G; Forcella C; Feliciani C; Murrell DF Ital J Dermatol Venerol; 2021 Apr; 156(2):147-150. PubMed ID: 33960750 [TBL] [Abstract][Full Text] [Related]
29. [Chronic bullous dermatoses of childhood in the differential diagnosis of bullous dermatitis in children]. Buffoni S; Salvai M Minerva Pediatr; 1995 Oct; 47(10):409-15. PubMed ID: 8569641 [TBL] [Abstract][Full Text] [Related]
30. [Immunology of bullous diseases (pemphigus vulgaris and bullous pemphigus)]. Diaz-Pérez JL Med Cutan Ibero Lat Am; 1976; 4(4):271-80. PubMed ID: 798081 [TBL] [Abstract][Full Text] [Related]
31. [Verapamil-induced linear IgA disease mimicking toxic epidermal necrolysis]. Schroeder D; Saada D; Rafaa M; Ingen-Housz-Oro S; Valeyrie-Allanore L; Sigal ML Ann Dermatol Venereol; 2011; 138(4):302-6. PubMed ID: 21497257 [TBL] [Abstract][Full Text] [Related]
32. Diffuse bullous eruption in a 3-month-old infant. Zebede MS; Anhalt GJ; Nsouli TM; Nsouli SM; Bellanti JA Ann Allergy; 1987 Jan; 58(1):12-3, 63-6. PubMed ID: 3541697 [No Abstract] [Full Text] [Related]
33. Management of autoimmune bullous diseases in France: a nationwide network of 30 centers. Meyer N; Paul C; Joly P Dermatol Clin; 2011 Oct; 29(4):659-62. PubMed ID: 21925014 [TBL] [Abstract][Full Text] [Related]
34. Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools. Paradisi A; Sampogna F; Di Pietro C; Cianchini G; Didona B; Ferri R; Abeni D; Tabolli S J Am Acad Dermatol; 2009 Feb; 60(2):261-9. PubMed ID: 19004524 [TBL] [Abstract][Full Text] [Related]
36. Oral involvement in autoimmune bullous diseases. Ramos-e-Silva M; Ferreira A; Jacques Cd Clin Dermatol; 2011; 29(4):443-54. PubMed ID: 21679873 [TBL] [Abstract][Full Text] [Related]
37. [Ultrastructural and immuno-electron-microscopic studies in linear IgA bullous dermatosis]. Dabrowski J; Chorzelski TP; Jabłońska S; Kraińska T; Jarzabek-Chorzelska M Przegl Dermatol; 1980; 67(5):541-8. PubMed ID: 7005970 [No Abstract] [Full Text] [Related]
38. Spectrum of autoimmune blistering dermatoses in Tunisia: an 11-year study and a review of the literature. Zaraa I; Kerkeni N; Ishak F; Zribi H; El Euch D; Mokni M; Osman AB Int J Dermatol; 2011 Aug; 50(8):939-44. PubMed ID: 21781064 [TBL] [Abstract][Full Text] [Related]
39. [Bullous autoimmune dermatoses. 3: Diagnosis and therapy]. Hertl M; Schuler G Hautarzt; 2002 May; 53(5):352-65; quiz 366-7. PubMed ID: 12063750 [No Abstract] [Full Text] [Related]
40. [Acute linear IgA bullous dermatosis with circulating IgA monoclonal antibody associated with Hodgkin's disease]. Gantzer A; Bouaziz JD; Valeyrie-Allanore L; Ingen-Housz-Oro S; Ortonne N; Bagot M Ann Dermatol Venereol; 2010 Dec; 137(12):819-20. PubMed ID: 21134587 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]